Three Silicon Valley entrepreneurs are offering $3 million to scientists demonstrating excellence in biology and medical research.
Three Silicon Valley entrepreneurs are offering $3 million to scientists demonstrating excellence in biology and medical research.
Disruptions in the interaction between nuclear and mitochondrial DNA can lead to deficiencies in the mitochondrial energy-generating process, affecting fitness.
Under new plans to reduce the European Union’s overall spending, science funding did relatively well, but research leaders want more—and they may well get it.
A study suggests that some mouse models do not accurately mimic human molecular mechanisms of inflammatory response, but other mouse strains may fare better.
Protein aggregates in the brains of some people with dementia or motor neuron disease have a surprising origin.
Engineer and materials scientist Subra Suresh will become president of Carnegie Mellon University.
One of the most advanced tuberculosis vaccines has failed to protect infants from getting the disease in a clinical trial, but it may be effective in adults.
After a 4-year stretch as US Energy Secretary, during which he fought to fund research on clean energy technology, Steven Chu has announced his resignation.
A new study disputes findings of a 2011 analysis suggesting that black researchers are funded less than their equally qualified white peers.
A company offering experimental stem-cell treatments will carry out its procedures in Mexico after the FDA warned that it would need approval to operate in the U.S.